Raytheon awarded $71 million in Navy contracts for missile systems
ProPhase Labs, Inc. (NASDAQ:PRPH) announced Thursday that it has terminated its Common Stock Purchase Agreement with Keystone Capital Partners, LLC. The agreement, originally dated January 29, 2025, established an equity line of credit facility allowing ProPhase Labs to sell shares of its common stock to Keystone for up to approximately $7.7 million. The company’s stock, which has declined nearly 86% over the past year and currently trades at $0.33, shows signs of being undervalued according to InvestingPro analysis.
According to a statement in the company’s SEC filing, ProPhase Labs delivered notice of termination to Keystone on Wednesday, with the termination becoming effective the next trading day. The company exercised its right to end the agreement at its sole discretion, as permitted by the terms of the facility, which allowed for termination at any time with one trading day’s prior written notice and without incurring any penalties or termination fees.
The company confirmed that, aside from the terminated agreement, there are no material relationships between ProPhase Labs or its affiliates and Keystone Capital Partners.
This information is based on a press release statement contained in a Form 8-K filing with the Securities and Exchange Commission.
In other recent news, ProPhase Labs reported its second-quarter earnings for 2025, revealing a mixed financial performance. The company posted an earnings per share (EPS) of -$0.11, which was better than the forecasted -$0.15, indicating a narrower-than-expected loss. However, ProPhase Labs experienced a significant revenue shortfall, with revenue plummeting to $1.25 million, well below the anticipated $3.55 million. Despite the EPS beat, the revenue miss was notable. These developments are part of the recent updates concerning the company’s financial health. No analyst upgrades or downgrades were reported in relation to these earnings results. Investors may find the revenue figures particularly significant as they assess the company’s recent performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.